GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Advanced Medical Solutions Group PLC (LSE:AMS) » Definitions » 5-Year Yield-on-Cost %

Advanced Medical Solutions Group (LSE:AMS) 5-Year Yield-on-Cost % : 2.08 (As of Dec. 14, 2024)


View and export this data going back to 2002. Start your Free Trial

What is Advanced Medical Solutions Group 5-Year Yield-on-Cost %?

Advanced Medical Solutions Group's yield on cost for the quarter that ended in Jun. 2024 was 2.08.


The historical rank and industry rank for Advanced Medical Solutions Group's 5-Year Yield-on-Cost % or its related term are showing as below:

LSE:AMS' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.47   Med: 0.88   Max: 2.25
Current: 2.08


During the past 13 years, Advanced Medical Solutions Group's highest Yield on Cost was 2.25. The lowest was 0.47. And the median was 0.88.


LSE:AMS's 5-Year Yield-on-Cost % is ranked better than
51.1% of 317 companies
in the Medical Devices & Instruments industry
Industry Median: 2.03 vs LSE:AMS: 2.08

Competitive Comparison of Advanced Medical Solutions Group's 5-Year Yield-on-Cost %

For the Medical Instruments & Supplies subindustry, Advanced Medical Solutions Group's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Advanced Medical Solutions Group's 5-Year Yield-on-Cost % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Advanced Medical Solutions Group's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Advanced Medical Solutions Group's 5-Year Yield-on-Cost % falls into.



Advanced Medical Solutions Group 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Advanced Medical Solutions Group is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Advanced Medical Solutions Group  (LSE:AMS) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Advanced Medical Solutions Group 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Advanced Medical Solutions Group's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Advanced Medical Solutions Group Business Description

Traded in Other Exchanges
Address
Premier Park, 33 Road One, Winsford Industrial Estate, Winsford, Cheshire, GBR, CW7 3RT
UK-based Advanced Medical Solutions was founded in 1991 to design, develop, and manufacture advanced wound-care products for other healthcare manufacturers. AMS' key branded products include the ActivHeal franchise of hydrogel, hydrocolloid, foam, and alginate wound dressings. The firm also manufactures and markets a suite of branded products in surgical use, including the LiquiBand franchise for tissue adhesion and the Resorba line of sutures and collagen-based products for tissue repair. The firm derives approximately 60% of total revenue from branded products, with nonbranded contributing 40%.